Business · 24/02/2026
FDA Renewal of Gastrointestinal Drugs Advisory Committee
The FDA is renewing the Gastrointestinal Drugs Advisory Committee for an additional 2 years, with a new charter set to expire on March 3, 2028.
Business · 24/02/2026
The FDA is renewing the Gastrointestinal Drugs Advisory Committee for an additional 2 years, with a new charter set to expire on March 3, 2028.
Explore insights